State Street’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.11M | Buy |
368,737
+196,882
| +115% | +$2.19M | ﹤0.01% | 3027 |
|
|
2025
Q1 | $2.11M | Buy |
171,855
+23,552
| +16% | +$289K | ﹤0.01% | 3225 |
|
|
2024
Q4 | $1.66M | Sell |
148,303
-7,187
| -5% | -$80.4K | ﹤0.01% | 3376 |
|
|
2024
Q3 | $1.08M | Buy |
155,490
+12,912
| +9% | +$90K | ﹤0.01% | 3467 |
|
|
2024
Q2 | $1.08M | Buy |
142,578
+105,327
| +283% | +$796K | ﹤0.01% | 3462 |
|
|
2024
Q1 | $492K | Buy |
37,251
+3,900
| +12% | +$51.5K | ﹤0.01% | 3653 |
|
|
2023
Q4 | $344K | Buy |
33,351
+100
| +0.3% | +$1.03K | ﹤0.01% | 3734 |
|
|
2023
Q3 | $324K | Buy |
33,251
+10,800
| +48% | +$105K | ﹤0.01% | 3784 |
|
|
2023
Q2 | $101K | Hold |
22,451
| – | – | ﹤0.01% | 4236 |
|
|
2023
Q1 | $104K | Hold |
22,451
| – | – | ﹤0.01% | 4313 |
|
|
2022
Q4 | $33.5K | Hold |
22,451
| – | – | ﹤0.01% | 4645 |
|
|
2022
Q3 | $84K | Hold |
22,451
| – | – | ﹤0.01% | 4522 |
|
|
2022
Q2 | $111K | Sell |
22,451
-76,266
| -77% | -$377K | ﹤0.01% | 4482 |
|
|
2022
Q1 | $810K | Buy |
98,717
+2,042
| +2% | +$16.8K | ﹤0.01% | 3871 |
|
|
2021
Q4 | $974K | Sell |
96,675
-930
| -1% | -$9.37K | ﹤0.01% | 3819 |
|
|
2021
Q3 | $1.55M | Buy |
97,605
+24,799
| +34% | +$393K | ﹤0.01% | 3683 |
|
|
2021
Q2 | $1.73M | Buy |
+72,806
| New | +$1.73M | ﹤0.01% | 3570 |
|